Related references
Note: Only part of the references are listed.Clonidine use in the outpatient management of severe secondary dystonia
C. Sayer et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2017)
A Post Hoc Study on Gene Panel Analysis for the Diagnosis of Dystonia
Martje E. van Egmond et al.
MOVEMENT DISORDERS (2017)
Gabapentin can significantly improve dystonia severity and quality of life in children
Natasha Yuan-Kim Liow et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2016)
Safety profile of incobotulinum toxin A [Xeomin®] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial
Elena Carraro et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2016)
Medication use in childhood dystonia
Daniel E. Lumsden et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2016)
Advances in management of movement disorders in children
Anne Koy et al.
LANCET NEUROLOGY (2016)
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology
David M. Simpson et al.
NEUROLOGY (2016)
Botulinum toxin type B for cervical dystonia
Raquel E. Marques et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Botulinumtoxin type A versus botulinumtoxin type B for cervical dystonia
Gonalo S. Duarte et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Childhood Dystonias
Samer D. Tabbal
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2015)
Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm
Martje E. van Egmond et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Dystonia: an update on phenomenology, classification, pathogenesis and treatment
Bettina Balint et al.
CURRENT OPINION IN NEUROLOGY (2014)
Levodopa Does Not Improve Function in Individuals with Dystonic Cerebral Palsy
Inna Pozin et al.
JOURNAL OF CHILD NEUROLOGY (2014)
SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype
Kathryn J. Peall et al.
JOURNAL OF NEUROLOGY (2014)
Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience
Francesco Motta et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2014)
Use of Intrathecal Baclofen in Children and Adolescents: Interdisciplinary Consensus Table 2013
Steffen Berweck et al.
NEUROPEDIATRICS (2014)
Drug-induced movement disorders in children at paediatric emergency department: 'dystonia'
Oksan Derinoz et al.
EMERGENCY MEDICINE JOURNAL (2013)
A Post-Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases
Kornelia Neveling et al.
HUMAN MUTATION (2013)
Primary Myoclonus-Dystonia: A Diagnosis Often Missed in Children
Debabrata Ghosh et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Phenomenology and classification of dystonia: A consensus update
Alberto Albanese et al.
MOVEMENT DISORDERS (2013)
Assessment of patients with isolated or combined dystonia: An update on dystonia syndromes
Victor S. C. Fung et al.
MOVEMENT DISORDERS (2013)
Special concerns in defining, studying, and treating dystonia in children
Jonathan W. Mink
MOVEMENT DISORDERS (2013)
Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
Jack J. Chen et al.
CLINICAL THERAPEUTICS (2012)
Autoimmune Basal Ganglia Disorders
Russell C. Dale et al.
JOURNAL OF CHILD NEUROLOGY (2012)
Stereotactic endoscopic placement of third ventricle catheter for long-term infusion of baclofen in patients with secondary generalized dystonia
Robert J. Bollo et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2012)
Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations Clinical article
Michael Turner et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2012)
Manucher Javid, Urea, and the Rise of Osmotic Therapy for Intracranial Pressure
Brandon G. Rocque
NEUROSURGERY (2012)
Transient idiopathic dystonia in infancy
Rita Calado et al.
ACTA PAEDIATRICA (2011)
Tetrabenazine For Chorea Associated with Huntington's Disease
Lesley J. Scott
CNS DRUGS (2011)
EFNS guidelines on diagnosis and treatment of primary dystonias
A. Albanese et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Trihexyphenidyl Improves Motor Function in Children with Dystonic Cerebral Palsy: A Retrospective Analysis
Hilla Ben-Pazi
JOURNAL OF CHILD NEUROLOGY (2011)
Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis
Julie Phukan et al.
LANCET NEUROLOGY (2011)
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Josep Dalmau et al.
LANCET NEUROLOGY (2011)
Use of Trihexyphenidyl in Children With Cerebral Palsy
Jorge Carranza-del Rio et al.
PEDIATRIC NEUROLOGY (2011)
Systemic Weakness After Therapeutic Injections of Botulinum Toxin A: A Case Series and Review of the Literature
Beth E. Crowner et al.
CLINICAL NEUROPHARMACOLOGY (2010)
A Case of Secondary Dystonia Responding to Levodopa
Genevieve Bernard et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Definition and Classification of Hyperkinetic Movements in Childhood
Terence D. Sanger et al.
MOVEMENT DISORDERS (2010)
Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in Children and Adolescents
Nicole R. Florance et al.
ANNALS OF NEUROLOGY (2009)
Dyskinetic cerebral palsy in Europe: trends in prevalence and severity
K. Himmelmann et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2009)
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia
Fabienne Clot et al.
BRAIN (2009)
Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials
Cidronio Albavera-Hernandez et al.
CLINICAL REHABILITATION (2009)
Pilot Study on Trihexyphenidyl in the Treatment of Dystonia in Children With Cerebral Palsy
James Rice et al.
JOURNAL OF CHILD NEUROLOGY (2009)
The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism
R. Pons
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study
Susan B. Bressman et al.
LANCET NEUROLOGY (2009)
Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study
Ana Djarmati et al.
LANCET NEUROLOGY (2009)
Myoclonus-Dystonia: An Update
Kiyoka Kinugawa et al.
MOVEMENT DISORDERS (2009)
Motor overflow and mirror dystonia
Oraporn Sitburana et al.
PARKINSONISM & RELATED DISORDERS (2009)
Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales
Francesco Motta et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2008)
Focal hand dystonia, mirror dystonia and motor overflow
Orapom Sitburana et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
The distinctive movement disorder of ovarian teratoma-associated encephalitis
Timothy J. Kleinig et al.
MOVEMENT DISORDERS (2008)
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson et al.
NEUROLOGY (2008)
Intrathecal Baclofen Withdrawal Resembling Serotonin Syndrome in an Adolescent Boy With Cerebral Palsy
Maria L. Salazar et al.
PEDIATRIC EMERGENCY CARE (2008)
High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy
Allison W. Willis et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2007)
The role of intrathecal baclofen in the management of primary and secondary dystonia in children
K. Woon et al.
BRITISH JOURNAL OF NEUROSURGERY (2007)
Structural white matter abnormalities in patients with idiopathic dystonia
Leonardo Bonilha et al.
MOVEMENT DISORDERS (2007)
Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy
Terence D. Sanger et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Dyskinetic cerebral palsy: a population-based study of children born between 1991 and 1998
K. Himmelmann et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2007)
Oral baclofen and clonidine for treatment of spasticity in children
Lisa Lubsch et al.
JOURNAL OF CHILD NEUROLOGY (2006)
Can spasticity and dystonia be independently measured in cerebral palsy?
Laurie M. Gordon et al.
PEDIATRIC NEUROLOGY (2006)
Tetrabenazine therapy of pediatric hyperkinetic movement disorders
Samay Jain et al.
MOVEMENT DISORDERS (2006)
Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia
Mattia Gambarin et al.
MOVEMENT DISORDERS (2006)
Metoclopramide induced dystonia in children: two case reports
Uluc Yis et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2005)
Long-term botulinum toxin efficacy, safety, and immunogenicity
NI Mejia et al.
MOVEMENT DISORDERS (2005)
Botulinum toxin type A versus anticholinergics for cervical dystonia
J Costa et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Botulinum toxin type A therapy for cervical dystonia
J Costa et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Tetrabenazine treatment in movement disorders
D Paleacu et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Microstructural white matter changes in carriers of the DYT1 gene mutation
M Carbon et al.
ANNALS OF NEUROLOGY (2004)
Safety of botulinum toxin type A: a systematic review and meta-analysis
M Naumann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options
Y Balash et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Biomechanic characteristics of patients with spastic and dystonic hypertonia in cerebral palsy
MK Lebiedowska et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2004)
Pathophysiology of pediatric movement disorders
TD Sanger
JOURNAL OF CHILD NEUROLOGY (2003)
Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature
M Edwards et al.
MOVEMENT DISORDERS (2003)
Classification and definition of disorders causing hypertonia in childhood
TD Sanger et al.
PEDIATRICS (2003)
Diagnostic criteria for dystonia in DYT1 families
SB Bressman et al.
NEUROLOGY (2002)
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study
R Baker et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2002)
Myoclonus-dystonia syndrome:: ε-sarcoglycan mutations and phenotype
F Asmus et al.
ANNALS OF NEUROLOGY (2002)
The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature
C Chuang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Intrathecal baclofen for generalized dystonia
AL Albright et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2001)
The long-term response to levodopa in dopa-responsive dystonia
WJ Hwang et al.
PARKINSONISM & RELATED DISORDERS (2001)
Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy
AH Hoon et al.
PEDIATRIC NEUROLOGY (2001)
Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
T Ubhi et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2000)
Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy
C Butler et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2000)
The DYT1 phenotype and guidelines for diagnostic testing
SB Bressman et al.
NEUROLOGY (2000)
Frequency analysis of EMG activity in patients with idiopathic torticollis
MAJ Tijssen et al.
BRAIN (2000)
Risperidone in idiopathic and symptomatic dystonia: preliminary experience
E Grassi et al.
NEUROLOGICAL SCIENCES (2000)
Frequency of adverse reactions to prochlorperazine in the ED
JC Olsen et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2000)